0

Tranilast

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP53902128
CAS53902-12-8
Structure
MDL NumberMFCD00864787
Molecular Weight327.33
InChI KeyNZHGWWWHIYHZNX-CSKARUKUSA-N
Description≥98% (HPLC), powder
SolubilityDMSO: >10 mg/mL; H2O: insoluble
Assay≥98% (HPLC)
Colorwhite to beige
Formpowder
MP166.2-168.2 °C (lit.)
Size10MG, 50MG
Storage Conditions2-8°C
1

Effects of Tranilast on the Epithelial-To-Mesenchymal Transition in Peritoneal Mesothelial Cells

Seok Hui Kang, Sang Woon Kim, Keuk Jun Kim, Kyu Hyang Cho, Jong Won Park, Chan-Duck Kim, Jun Young Do

Kidney Res Clin Pract. 2019 Dec 31;38(4):472-480.

PMID: 31554027

1

Safety and Tolerability of Available Urate-Lowering Drugs: A Critical Review

Larysa Strilchuk, Federica Fogacci, Arrigo Fg Cicero

Expert Opin Drug Saf. 2019 Apr;18(4):261-271.

PMID: 30915866

1

Tranilast Directly Targets NLRP3 to Treat Inflammasome-Driven Diseases

Yi Huang, Hua Jiang, Yun Chen, Xiaqiong Wang, Yanqing Yang, Jinhui Tao, Xianming Deng, Gaolin Liang, Huafeng Zhang, Wei Jiang, Rongbin Zhou

EMBO Mol Med. 2018 Apr;10(4):e8689.

PMID: 29531021

1

Tranilast Enhances the Effect of Anticancer Agents in Osteosarcoma

Takayuki Nakashima, Satoshi Nagano, Takao Setoguchi, Hiromi Sasaki, Yoshinobu Saitoh, Shingo Maeda, Setsuro Komiya, Noboru Taniguchi

Oncol Rep. 2019 Jul;42(1):176-188.

PMID: 31059083

1

Tranilast: A Review of Its Therapeutic Applications

Sara Darakhshan, Ali Bidmeshki Pour

Pharmacol Res. 2015 Jan;91:15-28.

PMID: 25447595

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode